We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
N4 Pharma Plc | LSE:N4P | London | Ordinary Share | GB00BYW8QM32 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.05 | -6.06% | 0.775 | 0.75 | 0.80 | 0.825 | 0.775 | 0.83 | 610,845 | 15:32:48 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Drug & Proprietary Stores | 0 | -1.03M | -0.0057 | -1.35 | 1.39M |
Date | Subject | Author | Discuss |
---|---|---|---|
25/8/2018 15:22 | Nobbo and Lewis, finally seen for the derampers that they are. Trying to trash the company so they can get in cheaper. Enough said. | hughwilson | |
24/8/2018 07:48 | dplewis1...to quote If it's completely illogical for a shareholder to criticise a company then why does the term 'shareholder rebellion' exist? It's not the role of a shareholder to buy some equity and then simply pump the stock on any forum he can Agreed its not the role of a shareholder to pump a stock for all its worth.....however it is understandable.....a Also shareholder rebellion is stretching it a bit as a reason for deriding the company constantly......we are not dealing with a multinational here. Regardless you, hugh and nobby always give me something to read everyday.....lol | thaiflyer1 | |
23/8/2018 17:16 | I'm not sure which actions of mine you are referring to or why you seem to think you have hit a nerve...I was merely pointing out that I don't agree that things are ever quite so cut and dried. People have many nuanced reasons for their actions, including shareholder rebellions, so placing everything into distinct pigeon holes seems like a bit of a lazy way to fit to a narrative. | dplewis1 | |
23/8/2018 16:25 | If it's completely illogical for a shareholder to criticise a company then why does the term 'shareholder rebellion' exist? It's not the role of a shareholder to buy some equity and then simply pump the stock on any forum he can without seeking out the potential downfalls. That would be incredibly naive. | dplewis1 | |
23/8/2018 15:57 | I am a shareholder and I will prove it to others on here I know well. What you guys don’t understand is that not everyone will just say what suits their position. I was in the process of selling out but had a few left. I am not now going to ramp the company but strangely just say it as it is. I actually did this before when I was a much larger shareholder to counteract hugh’s naivety and outrageous ramping. Some people don’t betray their principles to sell their granny.... Nobby | nobbygnome | |
23/8/2018 15:40 | Thaiflyer You can witness the same conundrum amongst posters on many stock forums. It doesn't make financial or common sense at all. Completely illogical. The overriding reason is obvious and straightforward. The clue is always in the following statement or variations, thereof. 'I am indeed a shareholder' It's a lie. Nothing more, nothing less, despite every claim or protest to the contrary. When you factor this in to the equation, the remainder makes absolute sense and the conundrum dissipates. | simpletonremover | |
23/8/2018 07:20 | Got to agree with featherby81......... We all know this one is just a punt at the moment but why not wait for something concrete to come straight from the horses mouth rather than bickering on this board day after day...... | thaiflyer1 | |
22/8/2018 10:06 | Well if nobody takes anything that is posted on here as impartial, then the only 3rd party objective comment came from the analyst at SCSW who said in his coverage in May, "One to look at again once the fundraising is out of the way as for the moment the shares appear to have run ahead of themselves."Time will tell if he's right about the fundraising but the comment about the share price was prescient. This was around the same time that Hugh was advising people to buy at 18.5p .. | dplewis1 | |
22/8/2018 10:02 | I have repeatedly said that Nuvec has potential.....but it is not as advanced as certain people have been telling us. Ho hum... | nobbygnome | |
22/8/2018 09:56 | Slated the products, slated the CEO and yet still fancy a dabble! Add to this not one positive comment about N4’s future. This makes your written (past and present) opinion void in my eyes. | featherby81 | |
22/8/2018 09:47 | >> featherby Of course everything has a value. N4P at 5p with say another £1 million in the coffers might be reasonable value. However, at 20 odd p there most definitely was no value and in fact it was really only there based on the hype of people like hugh. The sildenafil reformulation was doomed to fail IMHO and anyway it is the wrong drug at the wrong time. All a bit sad really..... | nobbygnome | |
22/8/2018 09:42 | Nobby, waiting for a bargain of an entry point.. knew it! | featherby81 | |
22/8/2018 09:32 | >> hugh I am indeed a shareholder but we are not all as myopic as you. I like to be realistic and have now realised that the company (and you) have seriously over hyped the current state of affairs. I am afraid you can't run away from the truth......even if you are a manic, myopic shareholder. You can keep ramping and misleading people but do you really think that is ethical? The truth will catch up with you eventually. Fund raising coming IMHO. I may participate if it is at the 5p level. Nobby | nobbygnome | |
22/8/2018 09:25 | Rubberbullets - I hope you're not right but the chart sure is ugly.....I got caught holding at 23.5p and have a significant % loss - but won't sell now as most of the damage is done. I've effectively written off the rest or am willing to gamble (because that's what it is) on better news.I do wonder what might happen to the share price in the absence of any firm news. I guess a slow drop might be expected until further news (good or bad) is announced so not particularly bothered by the drip drip drip. One for the 'lessons learned' pile for me and we'll see where we are in 6 or 12 months time..... | mktommo | |
22/8/2018 09:09 | In fact let's talk about your deramping of this stock Nobbo. You claim to be a shareholder. Every shareholder that I know of wants to see their shares rise. You, on the other hand, spend all your time trying to trash this company. Can you as a shareholder explain that. Far more likely is that you are not a shareholder and you are just trying to deramp to get in lower. | hughwilson | |
22/8/2018 08:50 | Nobbo, you are the one that is misleading people, either by design or because you are just so ill-informed. Both N4 and myself are quite clear in that the studies going on at the moment both by N4 and Medimmume include studies on your immune response. One thing is crystal clear here and that is your determination to trash the company, its CEO and anyone who is positive and all while claiming to be a shareholder with a minute amount of shares worth a few hundred, For that you are here 24/7 trying to trash everything I say. Clearly, an agenda going on here. | hughwilson | |
22/8/2018 08:46 | looks finished | rubberbullets | |
22/8/2018 08:28 | >> hugh I owe you thanks. You are proving that Nuvec is not nearly as advanced as you like to tell the world. Yes it is possible to deliver therapeutic proteins......but it is not actually happening as proven by the complete absence of any information in the June update. You are misleading everybody as to how far down the line of development the technology is. So thank you very much! Fund raising on the way shortly..... | nobbygnome | |
22/8/2018 08:21 | This project is co funded by Innovate UK, that’s more than supportive. Human Papilloma Virus (HPV) has been implicated in a range of cancers. Currently, a prophylactic vaccine is prescribed for adolescent girls with a view to prevent infection by HPV. However, this preventative vaccine does not have a therapeutic effect on malignancies developed as a result of HPV infection. In this regard, the use of nucleic acid vaccines for treatment of HPV related cancers has been considered, for which the proposed strategy is to induce antigen specific immune response to cancer cells in the body. As for many systems of this type the challenge is to deliver the plasmid DNA (pDNA) or messenger RNA (mRNA) effectively to antigen presenting cells, with a view to stimulating recognition and destruction of cancerous cells by the immune system. The challenge for pDNA vaccine delivery relates to the availability of suitable and safe non-viral vectors which have high loading capacity for pDNA and mRNA and are able to recruit antigen presenting cells to the site of injection, but do not elicit an excessive inflammatory response. In this regard, N4 Pharma have developed a novel vector (Nuvec), which has been demonstrated to provide high nucleic acid loading capacity and transfection in in-vitro and in-vivo experiments. This 9 month feasibility project will explore the manufacture of a prototype nanomedicine product using N4 Pharma's Nuvec system for delivery of a therapeutic HPV nucleic acid vaccine. It will focus on the design of a process for manufacturing Nuvec nanoparticles optimally loaded with pDNA and modified mRNA encoding antigens specific to HPV related malignancies. This will include evaluation of strategies for maximising loadings and reducing the levels of free nucleic acids in the formulation. | fireball xl5 | |
22/8/2018 06:55 | So why isn't it mentioned in the Nuvec update in June? A very simple question for you! There is clearly nothing happening in this regard at present and it is all about generating an immune response........as I said. So far there is no evidence that they can.... | nobbygnome | |
21/8/2018 23:15 | Nobbo, From 13.30 minutes onwards. Multiple uses for Nuvec in addition to vaccines. In effect, as a delivery system, it can be used for pretty much anything. | hughwilson | |
21/8/2018 22:32 | escapetohome, do you see any of the main shareholders selling- answer NO, confidence indeed. | hughwilson | |
21/8/2018 20:53 | Who cares about the arguments, the share price tells it all. DOWN DOWN DOWN AS PREDICTED. CONFIDENCE GONE . RIP. | escapetohome | |
21/8/2018 17:10 | This share has let itself go. Needs to get back on track | volsung |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions